Anti-inflammatory potential of Empagliflozin

Inflammopharmacology. 2021 Apr;29(2):573-576. doi: 10.1007/s10787-021-00797-9. Epub 2021 Mar 17.

Author

Markus Pirklbauer¹

Affiliation

¹ Department of Internal Medicine IV-Nephrology and Hypertension, Medical University Innsbruck, Anichstrasse 35, 6020, Innsbruck, Austria. markus.pirklbauer@i-med.ac.at.

No abstract available

Keywords: Anti-inflammatory potential; Empagliflozin; Human proximal tubulus; Nephroprotection; SGLT2 inhibition.

MeSH terms

Animals
Anti-Inflammatory Agents, Non-Steroidal / pharmacology*
Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
Benzhydryl Compounds / pharmacology*
Benzhydryl Compounds / therapeutic use
Glucosides / pharmacology*
Glucosides / therapeutic use
Humans
Hypoglycemic Agents / pharmacology
Hypoglycemic Agents / therapeutic use
Inflammation / drug therapy
Renal Insufficiency, Chronic / drug therapy
Renal Insufficiency, Chronic / pathology
Sodium-Glucose Transporter 2 Inhibitors / pharmacology*
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use

Substances

Anti-Inflammatory Agents, Non-Steroidal
Benzhydryl Compounds
Glucosides
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors
empagliflozin